Terms: = Bone cancer AND SUZ12, CHET9, 23512, ENSG00000178691, Q15022, KIAA0160, JJAZ1
15 results:
1. Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3.
Park S; Yun J; Choi SY; Jeong D; Gu JY; Lee JS; Seong MW; Chang YH; Yun H; Kim HK
Sci Rep; 2023 May; 13(1):7280. PubMed ID: 37142644
[TBL] [Abstract] [Full Text] [Related]
2. Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development.
van Wijnen AJ; Bagheri L; Badreldin AA; Larson AN; Dudakovic A; Thaler R; Paradise CR; Wu Z
Bone; 2021 Feb; 143():115659. PubMed ID: 32979540
[TBL] [Abstract] [Full Text] [Related]
3. The 2020 WHO Classification: What's New in Soft Tissue Tumor Pathology?
Kallen ME; Hornick JL
Am J Surg Pathol; 2021 Jan; 45(1):e1-e23. PubMed ID: 32796172
[TBL] [Abstract] [Full Text] [Related]
4. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
[TBL] [Abstract] [Full Text] [Related]
5. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.
Yeh TC; Liang DC; Liu HC; Jaing TH; Chen SH; Hou JY; Yang CP; Huang YJ; Yao HW; Huang TY; Lin TH; Shih LY
Pediatr Blood Cancer; 2019 Jan; 66(1):e27496. PubMed ID: 30280491
[TBL] [Abstract] [Full Text] [Related]
6. Elevated expression of the EZH2 gene in CALR-mutated patients with primary myelofibrosis.
Fan N; Tang Y; Wu Z; Guan M; Chen B; Xu X; Ma W; Xu X; Zhang X
Ann Hematol; 2018 Jul; 97(7):1193-1208. PubMed ID: 29560522
[TBL] [Abstract] [Full Text] [Related]
7. Extraskeletal osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity.
Makise N; Sekimizu M; Kubo T; Wakai S; Watanabe SI; Kato T; Kinoshita T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Histopathology; 2018 Jul; 73(1):147-156. PubMed ID: 29489027
[TBL] [Abstract] [Full Text] [Related]
8. Expression profile of polycomb group proteins in odontogenic keratocyst and ameloblastoma.
Lapthanasupkul P; Juengsomjit R; Poomsawat S; Arayapisit T
Acta Histochem; 2018 Apr; 120(3):215-220. PubMed ID: 29415809
[TBL] [Abstract] [Full Text] [Related]
9. Malignant Peripheral Nerve Sheath Tumor of the Femur: A Rare Diagnosis Supported by Complete Immunohistochemical Loss of H3K27me3.
Sugawara M; Kobayashi E; Asano N; Yoshida A; Kawai A
Int J Surg Pathol; 2017 Oct; 25(7):629-634. PubMed ID: 28508686
[TBL] [Abstract] [Full Text] [Related]
10. Evaluating of suppressor of zeste 12 and chromobox homolog 8 genes expression showed two possible origins for gastric cancer development.
Ghalandary M; Behmanesh M; Sadeghizadeh M
Indian J Cancer; 2015; 52(1):27-31. PubMed ID: 26837964
[TBL] [Abstract] [Full Text] [Related]
11. Megakaryocytic hyperplasia in myeloproliferative neoplasms is driven by disordered proliferative, apoptotic and epigenetic mechanisms.
Malherbe JA; Fuller KA; Arshad A; Nangalia J; Romeo G; Hall SL; Meehan KS; Guo B; Howman R; Erber WN
J Clin Pathol; 2016 Feb; 69(2):155-63. PubMed ID: 26290261
[TBL] [Abstract] [Full Text] [Related]
12. Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.
Score J; Hidalgo-Curtis C; Jones AV; Winkelmann N; Skinner A; Ward D; Zoi K; Ernst T; Stegelmann F; Döhner K; Chase A; Cross NC
Blood; 2012 Feb; 119(5):1208-13. PubMed ID: 22053108
[TBL] [Abstract] [Full Text] [Related]
13. suz12 is a candidate target of the non-canonical WNT pathway in the progression of chronic myeloid leukemia.
Pizzatti L; Binato R; Cofre J; Gomes BE; Dobbin J; Haussmann ME; D'Azambuja D; Bouzas LF; Abdelhay E
Genes Chromosomes Cancer; 2010 Feb; 49(2):107-18. PubMed ID: 19847889
[TBL] [Abstract] [Full Text] [Related]
14. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.
Fiskus W; Wang Y; Sreekumar A; Buckley KM; Shi H; Jillella A; Ustun C; Rao R; Fernandez P; Chen J; Balusu R; Koul S; Atadja P; Marquez VE; Bhalla KN
Blood; 2009 Sep; 114(13):2733-43. PubMed ID: 19638619
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2.
Burdach S; Plehm S; Unland R; Dirksen U; Borkhardt A; Staege MS; Müller-Tidow C; Richter GH
Cell Cycle; 2009 Jul; 8(13):1991-6. PubMed ID: 19502792
[TBL] [Abstract] [Full Text] [Related]
